IDEAS home Printed from https://ideas.repec.org/a/gam/jsusta/v17y2025i6p2417-d1608938.html
   My bibliography  Save this article

Innovation as an Attribute of the Sustainable Development of Pharmaceutical Companies

Author

Listed:
  • Ewa Chomać-Pierzecka

    (University College of Professional Education in Wrocław, 53-329 Wrocław, Poland)

Abstract

An orientation towards strengthening the competitiveness of enterprises through an effective response to market expectations is nowadays associated with sustainable development. Despite the articulation of the role of innovative solutions in this respect, the literature has not sufficiently explored this issue. Hence, the aim of the article was to analyse the impact of innovation on the sustainable development of enterprises in the pharmaceutical sector operating in the market in Poland. For the purposes of this study, the scope and spectrum of reference for innovative solutions in pharmaceutical entities was diagnosed based on the results of a diagnostic survey. In part of the in-depth study, an assessment of the impact of innovation on the sustainable development of the surveyed enterprises was conducted. The above was performed using appropriately selected methods of a qualitative and quantitative nature, including economic analytical techniques (cause-effect analysis, dependency analysis). The research sample was made up of companies operating on the pharmaceutical market in Poland; therefore, the results of the research refer only to these entities and there are no grounds for transferring them to the general population of enterprises in this sector in the country under study. This paper’s findings indicate that the idea of creating added value, growing out of a broad concern for social, environmental and economic aspects, is determined by an innovative approach that enhances environmental security, responding to societal expectations, while at the same time aiming to maximise the economic impact on activities. Companies that invest more heavily in innovation achieve better results in sustainable development, as confirmed by research. Companies are aware of this and are directing development expenditure into solutions that strengthen their ability to respond effectively to market expectations, with the strongest implementation of the above based on product innovation.

Suggested Citation

  • Ewa Chomać-Pierzecka, 2025. "Innovation as an Attribute of the Sustainable Development of Pharmaceutical Companies," Sustainability, MDPI, vol. 17(6), pages 1-20, March.
    • Handle: RePEc:gam:jsusta:v:17:y:2025:i:6:p:2417-:d:1608938
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2071-1050/17/6/2417/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/2071-1050/17/6/2417/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Mary M. Crossan & Marina Apaydin, 2010. "A Multi‐Dimensional Framework of Organizational Innovation: A Systematic Review of the Literature," Journal of Management Studies, Wiley Blackwell, vol. 47(6), pages 1154-1191, September.
    2. Adam J. Bock & Tore Opsahl & Gerard George & David M. Gann, 2012. "The Effects of Culture and Structure on Strategic Flexibility during Business Model Innovation," Journal of Management Studies, Wiley Blackwell, vol. 49(2), pages 279-305, March.
    3. Jaffar Abbas & Iftikhar Hussain & Safdar Hussain & Sabahat Akram & Imrab Shaheen & Ben Niu, 2019. "The Impact of Knowledge Sharing and Innovation on Sustainable Performance in Islamic Banks: A Mediation Analysis through a SEM Approach," Sustainability, MDPI, vol. 11(15), pages 1-25, July.
    4. Xiao Xiao & Yue Cheng & Yuling Zhang, 2024. "Sustainable Innovation in the Biopharmaceutical Industry: An Analysis of the Impact of Policy Configuration," Sustainability, MDPI, vol. 16(6), pages 1-23, March.
    5. Gittelman, Michelle, 2006. "National institutions, public-private knowledge flows, and innovation performance: A comparative study of the biotechnology industry in the US and France," Research Policy, Elsevier, vol. 35(7), pages 1052-1068, September.
    6. Matthias Filser & Sascha Kraus & Norat Roig-Tierno & Norbert Kailer & Ulrike Fischer, 2019. "Entrepreneurship as Catalyst for Sustainable Development: Opening the Black Box," Sustainability, MDPI, vol. 11(16), pages 1-18, August.
    7. Hollenstein, Heinz, 2003. "Innovation modes in the Swiss service sector: a cluster analysis based on firm-level data," Research Policy, Elsevier, vol. 32(5), pages 845-863, May.
    8. Li-Min Chuang & Yu-Po Lee & Te-Hui Liu, 2022. "Towards Sustainable Business Model Innovation for the Pharmaceutical Industry," Sustainability, MDPI, vol. 14(18), pages 1-23, September.
    9. Kafouros, Mario & Wang, Chengqi & Piperopoulos, Panagiotis & Zhang, Mingshen, 2015. "Academic collaborations and firm innovation performance in China: The role of region-specific institutions," Research Policy, Elsevier, vol. 44(3), pages 803-817.
    10. Hall, Bronwyn H, 1993. "The Stock Market's Valuation of R&D Investment during the 1980's," American Economic Review, American Economic Association, vol. 83(2), pages 259-264, May.
    11. Esben Rahbek Gjerdrum Pedersen & Wencke Gwozdz & Kerli Kant Hvass, 2018. "Exploring the Relationship Between Business Model Innovation, Corporate Sustainability, and Organisational Values within the Fashion Industry," Journal of Business Ethics, Springer, vol. 149(2), pages 267-284, May.
    12. Seunghyun Park & Surender Reddy Salkuti, 2019. "Optimal Energy Management of Railroad Electrical Systems with Renewable Energy and Energy Storage Systems," Sustainability, MDPI, vol. 11(22), pages 1-16, November.
    13. Rammer, Christian, 2023. "Measuring process innovation output in firms: Cost reduction versus quality improvement," Technovation, Elsevier, vol. 124(C).
    14. Fumio Teramae & Tomohiro Makino & Yeongjoo Lim & Shintaro Sengoku & Kota Kodama, 2020. "Impact of Research and Development Strategy on Sustainable Growth in Multinational Pharmaceutical Companies," Sustainability, MDPI, vol. 12(13), pages 1-15, July.
    15. Anna Sobczak & Ewa Chomać-Pierzecka, 2024. "Challenges and Opportunities for the Development of Polish Enterprises in the Face of Crisis Threats," World, MDPI, vol. 5(2), pages 1-18, June.
    16. Kent Daniel & Sheridan Titman, 2006. "Market Reactions to Tangible and Intangible Information," Journal of Finance, American Finance Association, vol. 61(4), pages 1605-1643, August.
    17. Kyle J. Mayer & Zhe (Adele) Xing & Pablo Mondal, 2022. "Contracting for innovation: Designing contracts that account for exchange hazards and the need for innovation," Strategic Management Journal, Wiley Blackwell, vol. 43(11), pages 2253-2278, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ewa Chomać-Pierzecka, 2023. "Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management," Sustainability, MDPI, vol. 15(11), pages 1-23, May.
    2. Hameeda A. AlMalki & Christopher M. Durugbo, 2023. "Systematic review of institutional innovation literature: towards a multi-level management model," Management Review Quarterly, Springer, vol. 73(2), pages 731-785, June.
    3. David Hirshleifer & Po-Hsuan Hsu & Dongmei Li, 2018. "Innovative Originality, Profitability, and Stock Returns," The Review of Financial Studies, Society for Financial Studies, vol. 31(7), pages 2553-2605.
    4. Chen, Tao & Park, Hyeyoun & Rajwani, Tazeeb, 2024. "Diverse human resource slack and firm innovation: Evidence from politically connected firms," International Business Review, Elsevier, vol. 33(2).
    5. Chan, Konan & Lin, Yueh-hsiang & Wang, Yanzhi, 2015. "The information content of R&D reductions," Journal of Empirical Finance, Elsevier, vol. 34(C), pages 131-155.
    6. Ewa Chomać-Pierzecka & Joanna Rogozińska-Mitrut & Monika Różycka & Dariusz Soboń & Jacek Stasiak, 2023. "Energy Innovation for Individual Consumers in Poland—Analysis of Potential and Evaluation of Practical Applications in Selected Areas," Energies, MDPI, vol. 16(15), pages 1-21, August.
    7. Alessandro Da Giau & Nicolai J. Foss & Andrea Furlan & Andrea Vinelli, 2020. "Sustainable development and dynamic capabilities in the fashion industry: A multi‐case study," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 27(3), pages 1509-1520, May.
    8. Hsu, David H. & Hsu, Po-Hsuan & Zhao, Qifeng, 2021. "Rich on paper? Chinese firms’ academic publications, patents, and market value," Research Policy, Elsevier, vol. 50(9).
    9. Wang, Chengqi & Kafouros, Mario & Yi, Jingtao & Hong, Junjie & Ganotakis, Panagiotis, 2020. "The role of government affiliation in explaining firm innovativeness and profitability in emerging countries: Evidence from China," Journal of World Business, Elsevier, vol. 55(3).
    10. Bhatti, Sabeen Hussain & Santoro, Gabriele & Khan, Jabran & Rizzato, Fabio, 2021. "Antecedents and consequences of business model innovation in the IT industry," Journal of Business Research, Elsevier, vol. 123(C), pages 389-400.
    11. Farchi, Tomas & Salge, Torsten-Oliver, 2017. "Shaping innovation in health care: A content analysis of innovation policies in the English NHS, 1948–2015," Social Science & Medicine, Elsevier, vol. 192(C), pages 143-151.
    12. Saad, Mohsen & Zantout, Zaher, 2009. "Stock price and systematic risk effects of discontinuation of corporate R&D programs," Journal of Empirical Finance, Elsevier, vol. 16(4), pages 568-581, September.
    13. Vatankhah, Sanaz & Bamshad, Vahideh & Altinay, Levent & De Vita, Glauco, 2023. "Understanding business model development through the lens of complexity theory: Enablers and barriers," Journal of Business Research, Elsevier, vol. 155(PA).
    14. Imran M. Ilyas & Nadine Kammerlander & Roxana Turturea & Marc van Essen, 2024. "When Business Model Innovation Creates Value for Companies: A Meta‐Analysis on Institutional Contingencies," Journal of Management Studies, Wiley Blackwell, vol. 61(5), pages 1825-1883, July.
    15. Leung, Woon Sau & Evans, Kevin P. & Mazouz, Khelifa, 2020. "The R&D anomaly: Risk or mispricing?," Journal of Banking & Finance, Elsevier, vol. 115(C).
    16. Eng K. Chew, 2016. "iSIM: An integrated design method for commercializing service innovation," Information Systems Frontiers, Springer, vol. 18(3), pages 457-478, June.
    17. Ju, Xiaosheng & Jiang, Shengjun & Zhao, Qifeng, 2023. "Innovation effects of academic executives: Evidence from China," Research Policy, Elsevier, vol. 52(3).
    18. David Rooney & Tom Mandeville & Tim Kastelle, 2013. "Abstract Knowledge and Reified Financial Innovation: Building Wisdom and Ethics Into Financial Innovation Networks," Journal of Business Ethics, Springer, vol. 118(3), pages 447-459, December.
    19. David Hirshleifer & Danling Jiang, 2010. "A Financing-Based Misvaluation Factor and the Cross-Section of Expected Returns," The Review of Financial Studies, Society for Financial Studies, vol. 23(9), pages 3401-3436.
    20. Swen Nadkarni & Reinhard Prügl, 2021. "Digital transformation: a review, synthesis and opportunities for future research," Management Review Quarterly, Springer, vol. 71(2), pages 233-341, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jsusta:v:17:y:2025:i:6:p:2417-:d:1608938. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.